News Home

Do Analysts Expect Emergent Biosolutions Inc (EBS) Stock to Rise After It Has Fallen -28.26% in a Month?

Friday, September 22, 2023 12:42 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Emergent Biosolutions Inc (EBS) Stock to Rise After It Has Fallen -28.26% in a Month?

Wall Street is positive on Emergent Biosolutions Inc (EBS). On average, analysts give EBS a Hold rating. The average price target is $16.5, which means analysts expect the stock to add by 407.69% over the next twelve months. That average ranking earns EBS an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3
Wall Street analysts are rating EBS a Hold today. Find out what this means to you and get the rest of the rankings on EBS!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Emergent Biosolutions Inc Stock Today?

Emergent Biosolutions Inc (EBS) stock has fallen -5.52% while the S&P 500 is higher by 0.54% as of 12:32 PM on Friday, Sep 22. EBS is lower by -$0.19 from the previous closing price of $3.44 on volume of 569,916 shares. Over the past year the S&P 500 is up 15.84% while EBS is lower by -84.63%. EBS lost -$12.08 per share the over the last 12 months. Click Here to get the full Stock Report for Emergent Biosolutions Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App